NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED delivers three times its investment and a 36 percent internal rate of return with the sale of Italian dental services chain, Primo Group
October
15,
2019
ARCHIMED expands neurodiagnostic business in Europe and the US
September
23,
2019
Bomi Group further expands in LATAM and completes the acquisition of ILS Corporation in Ecuador and Peru
August
14,
2019
368